Related Experiment Video
Updated: May 17, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Using palliative care in progressive neuromuscular disease to maximize quality of life
Gregory T Carter1, Nanette C Joyce, Allison L Abresch
1Department of Physical Medicine and Rehabilitation, University of California at Davis, Sacramento, CA 95817, USA. gtcarter@uw.edu
Abstract:
This article discusses the role of palliative care in the treatment pathway of patients with progressive neuromuscular disease (NDM), including amyotrophic lateral sclerosis and Duchenne muscular dystrophy (DMD). People with severe NMDs like DMD are now living much longer, well in to adulthood. This makes them suitable for the medical model of palliative care. Yet palliative medicine is a new area, especially for "adults" with DMD. Strategies for identifying the most effective modalities to alleviate suffering in patients with an NMD receiving palliative services and creating best practice standards in pain and symptom management for this patient population are discussed.
Related Concept Videos
Continuing Care
Parkinson's Disease: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Peripheral Artery Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

